Literature DB >> 12748383

Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs.

Jacek Bania1, Evelina Gatti, Hugues Lelouard, Alexandre David, Fanny Cappello, Ekkehard Weber, Voahirana Camosseto, Philippe Pierre.   

Abstract

MHC class II-restricted antigen presentation plays a central role in the immune response against exogenous antigens. The association of invariant (Ii) chain with MHC class II dimers is required for proper antigen presentation to CD4+ T cells by antigen-presenting cells. MHC class II complexes first traffic through the endocytic pathway to allow Ii chain degradation and antigenic peptide loading before their arrival at the cell surface. In recent years, a considerable effort has been directed toward the identification of proteases responsible for Ii chain degradation. Targeted gene deletion in mice has allowed a precise description of the cysteine proteases involved in the last step of Ii chain degradation. By using nonspecialized cellular models expressing MHC II molecules, we are now exploring the contribution of known cysteine proteases to human Ii chain processing. Surprisingly and contrary to the situation in mouse, cathepsin S was found to be the only human cysteine protease able to efficiently degrade the Ii-p10 fragment in epithelial cells. This selectivity has implications for thymic selection and indicates that differences between man and mice are probably more profound at this level than expected.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12748383      PMCID: PMC164504          DOI: 10.1073/pnas.1131604100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Antigen processing in the endocytic compartment.

Authors:  C Watts
Journal:  Curr Opin Immunol       Date:  2001-02       Impact factor: 7.486

2.  Control of antigen presentation by a single protease cleavage site.

Authors:  A N Antoniou; S L Blackwood; D Mazzeo; C Watts
Journal:  Immunity       Date:  2000-04       Impact factor: 31.745

Review 3.  Cathepsins and compartmentalization in antigen presentation.

Authors:  R J Riese; H A Chapman
Journal:  Curr Opin Immunol       Date:  2000-02       Impact factor: 7.486

Review 4.  Presentation of antigens by MHC class II molecules: getting the most out of them.

Authors:  J A Villadangos
Journal:  Mol Immunol       Date:  2001-09       Impact factor: 4.407

Review 5.  Trafficking of MHC class II molecules in the late secretory pathway.

Authors:  Elizabeth M Hiltbold; Paul A Roche
Journal:  Curr Opin Immunol       Date:  2002-02       Impact factor: 7.486

Review 6.  Lysosomal cysteine proteases: facts and opportunities.

Authors:  V Turk; B Turk; D Turk
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

7.  Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S.

Authors:  R J Riese; G P Shi; J Villadangos; D Stetson; C Driessen; A M Lennon-Dumenil; C L Chu; Y Naumov; S M Behar; H Ploegh; R Locksley; H A Chapman
Journal:  Immunity       Date:  2001-12       Impact factor: 31.745

8.  The p41 isoform of invariant chain is a chaperone for cathepsin L.

Authors:  A M Lennon-Duménil; R A Roberts; K Valentijn; C Driessen; H S Overkleeft; A Erickson; P J Peters; E Bikoff; H L Ploegh; P Wolf Bryant
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

9.  Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice.

Authors:  T Y Nakagawa; W H Brissette; P D Lira; R J Griffiths; N Petrushova; J Stock; J D McNeish; S E Eastman; E D Howard; S R Clarke; E F Rosloniec; E A Elliott; A Y Rudensky
Journal:  Immunity       Date:  1999-02       Impact factor: 31.745

10.  Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages.

Authors:  A Punturieri; S Filippov; E Allen; I Caras; R Murray; V Reddy; S J Weiss
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307

View more
  24 in total

1.  Expression and characterization of cathepsin P.

Authors:  Robert W Mason; Carolyn A Bergman; Guizhen Lu; Jennifer Frenck Holbrook; Katia Sol-Church
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

Review 2.  Presentation of cytosolic antigens via MHC class II molecules.

Authors:  Delu Zhou; Janice S Blum
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments.

Authors:  Peter J McCormick; José A Martina; Juan S Bonifacino
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

4.  Independent and cooperative antiviral actions of beta interferon and gamma interferon against herpes simplex virus replication in primary human fibroblasts.

Authors:  Tao Peng; Jia Zhu; Yon Hwangbo; Lawrence Corey; Roger E Bumgarner
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

Review 5.  Cysteinyl cathepsins in cardiovascular diseases.

Authors:  Xian Zhang; Songyuan Luo; Minjie Wang; Guo-Ping Shi
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-01-09       Impact factor: 3.036

6.  Tollip-induced down-regulation of MARCH1.

Authors:  Marie-Claude Bourgeois-Daigneault; Abdul Mohammad Pezeshki; Tristan Galbas; Mathieu Houde; Martin Baril; Klaus Früh; Abdelaziz Amrani; Satoshi Ishido; Daniel Lamarre; Jacques Thibodeau
Journal:  Results Immunol       Date:  2013-02-20

7.  Selective cathepsin S inhibition attenuates atherosclerosis in apolipoprotein E-deficient mice with chronic renal disease.

Authors:  Jose-Luiz Figueiredo; Masanori Aikawa; Chunyu Zheng; Jacob Aaron; Lilian Lax; Peter Libby; Jose Luiz de Lima Filho; Sabine Gruener; Jürgen Fingerle; Wolfgang Haap; Guido Hartmann; Elena Aikawa
Journal:  Am J Pathol       Date:  2015-02-10       Impact factor: 4.307

Review 8.  Development of T-cell tolerance utilizes both cell-autonomous and cooperative presentation of self-antigen.

Authors:  Justin S A Perry; Chyi-Song Hsieh
Journal:  Immunol Rev       Date:  2016-05       Impact factor: 12.988

9.  Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis.

Authors:  Eva Tolosa; Weijie Li; Yoshiyuki Yasuda; Wolfgang Wienhold; Lisa K Denzin; Alfred Lautwein; Christoph Driessen; Petra Schnorrer; Ekkehard Weber; Stefan Stevanovic; Raffael Kurek; Arthur Melms; Dieter Bromme
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

10.  MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation.

Authors:  Aude De Gassart; Voahirana Camosseto; Jacques Thibodeau; Maurizio Ceppi; Nadia Catalan; Philippe Pierre; Evelina Gatti
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.